Replies to post #356132 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Why did CRL overpay if not for Cognate still owning an interest in NWBO?


If not shares in NWBO then revenue projections made by CRL are far too conservative.

[biosectinvestor]

It’s not illogical. While Cognate is not required to report changes in ownership because 12 M shares is below the requirement, it is in NWBO financial reports. And while that is not as frequently updated, it is correct as of the last time it was reported in an NWBO financial report. We will see if it changes in the next report covering that subject.